WO2006050734A3
(en )
2006-08-03
Potent lna oligonucleotides for the inhibition of hif-1a expression
HK1244504A1
(zh )
2018-08-10
反義設計
WO2004009769A3
(en )
2006-04-13
COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
BRPI0418104A
(pt )
2007-04-17
compostos oligoméricos para a modulação de bcl-2
EP1604010A4
(en )
2006-10-25
COMPOSITIONS AND METHODS FOR INHIBITING ICAM-1 GENE BY LOW INHIBITION RNA
WO2003100017A3
(en )
2004-08-26
Oligonucleotides having modified nucleoside units
IL300119A
(en )
2023-03-01
Oligonucleotides to induce paternal UBE3A expression
EP2213736A3
(de )
2010-09-01
Verfahren zur Hemmung der Expression eines Zielgens und Medikament zur Therapie einer Tumorerkrankung
DE69934227D1
(de )
2007-01-11
Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide
WO2009017803A3
(en )
2009-04-09
Antisense microrna and uses therefor
EP1750771A4
(en )
2007-11-07
PANCREATIC ILOT MICRO-RNA AND METHODS OF INHIBITING THE SAME
WO2004044139A3
(en )
2005-02-10
Modified oligonucleotides for use in rna interference
ATE508188T1
(de )
2011-05-15
Oligonukleotid-zusammensetzungen mit verbesserter wirksamkeit
EP2002018A4
(en )
2009-03-25
ANTIVIRAL ANTISENSE COMPOUND AND METHOD FOR THE TREATMENT OF ARENA VIRUS INFECTION
MXPA05011221A
(es )
2006-02-17
Composiciones y metodos para la inhibicion de angiopoyetina 1 y 2 y su receptor tie2 por arnsi.
MX2020009765A
(es )
2021-01-08
Oligonucleotido antisentido reducido en toxicidad.
AU2014208251B2
(en )
2016-07-14
Carbohydrate conjugates as delivery agents for oligonucleotides
WO2007117121A3
(en )
2007-12-27
Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent
HK1113318A1
(en )
2008-10-03
Oligonucleotide and compositions comprising the same for treating b cell neoplasm
UA93188C2
(ru )
2011-01-25
Эффективные олигонуклеотиды lna для ингибирования экспрессии hif-1a
Peyman et al.
1997
Nuclease stability as dominant factor in the antiviral activity of oligonucleotides directed against HSV-1 IE110
DE10346721A1
(de )
2005-05-04
Oligonukleotide, diese enthaltende Mittel und deren Verwendung
Rivory et al.
2006
The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity
EP1707630A4
(en )
2007-01-24
Antisense oligonucleotide with anti-cancer activity
WO2005026359A3
(en )
2005-09-09
The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases